Analysts Expect MedEquities Realty Trust Inc (MRT) Will Announce Quarterly Sales of $16.08 Million

Wall Street analysts predict that MedEquities Realty Trust Inc (NYSE:MRT) will announce $16.08 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for MedEquities Realty Trust’s earnings. The lowest sales estimate is $15.14 million and the highest is $16.79 million. MedEquities Realty Trust posted sales of $16.72 million in the same quarter last year, which suggests a negative year over year growth rate of 3.8%. The business is expected to report its next earnings report on Thursday, May 9th.

On average, analysts expect that MedEquities Realty Trust will report full-year sales of $65.86 million for the current fiscal year, with estimates ranging from $62.16 million to $67.90 million. For the next fiscal year, analysts anticipate that the firm will report sales of $70.80 million, with estimates ranging from $70.29 million to $71.30 million. Zacks’ sales averages are an average based on a survey of analysts that follow MedEquities Realty Trust.

A number of equities research analysts recently commented on MRT shares. TheStreet raised shares of MedEquities Realty Trust from a “d+” rating to a “c-” rating in a report on Wednesday, January 16th. ValuEngine upgraded shares of MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research report on Tuesday, January 29th. Finally, Zacks Investment Research upgraded shares of MedEquities Realty Trust from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 22nd. Ten equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $10.89.

NYSE:MRT opened at $11.08 on Friday. The company has a market capitalization of $348.97 million, a P/E ratio of 9.70 and a beta of 1.64. MedEquities Realty Trust has a 12 month low of $6.27 and a 12 month high of $11.85.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of MedEquities Realty Trust by 7.0% during the 3rd quarter. Vanguard Group Inc. now owns 3,151,744 shares of the financial services provider’s stock valued at $30,635,000 after purchasing an additional 205,635 shares in the last quarter. Vanguard Group Inc grew its position in shares of MedEquities Realty Trust by 7.0% during the 3rd quarter. Vanguard Group Inc now owns 3,151,744 shares of the financial services provider’s stock valued at $30,635,000 after purchasing an additional 205,635 shares in the last quarter. Prudential Financial Inc. grew its position in shares of MedEquities Realty Trust by 41.0% during the 4th quarter. Prudential Financial Inc. now owns 2,603,235 shares of the financial services provider’s stock valued at $17,806,000 after purchasing an additional 756,318 shares in the last quarter. BlackRock Inc. grew its position in shares of MedEquities Realty Trust by 21.4% during the 1st quarter. BlackRock Inc. now owns 2,141,829 shares of the financial services provider’s stock valued at $23,839,000 after purchasing an additional 376,922 shares in the last quarter. Finally, Alpine Associates Management Inc. purchased a new position in shares of MedEquities Realty Trust during the 1st quarter valued at $17,385,000. Hedge funds and other institutional investors own 88.82% of the company’s stock.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Featured Article: Swap

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply